Skip to main content

Abbott Laboratories Established Pharmaceuticals revenue

  • ABT · NYSE
  • Pharmaceuticals
  • Health Care Equipment
  • S&P 500
$108.52+1.18%Close 13 Nov 2026 · Market value $187.6B

Established Pharmaceuticals revenue at Abbott Laboratories came to $1.6B for the quarter to 30 Sep 2026, up 6.8% from a year earlier.

As Abbott Laboratories reported it in its earnings release and quarterly or annual report, compiled and checked by AapWire. Latest figure filed 4 Nov 2026.

By quarter

$1.2BDec 2023$1.2BMar 2024$1.3BJun 2024$1.4BSep 2024$1.3BDec 2024$1.3BMar 2025$1.4BJun 2025$1.5BSep 2025$1.4BDec 2025$1.4BMar 2026$1.5BJun 2026$1.6BSep 2026
Abbott Laboratories Established Pharmaceuticals revenue, every reported period
Period endingEstablished Pharmaceuticals revenueChange on a yearFiled
30 Sep 2026$1.6Bup 6.8%4 Nov 2026
30 Jun 2026$1.5Bup 8.4%28 Jul 2026
31 Mar 2026$1.4Bup 13.2%29 Apr 2026
31 Dec 2025$1.4Bup 9.0%20 Feb 2026
30 Sep 2025$1.5Bup 7.5%29 Oct 2025
30 Jun 2025$1.4Bup 6.9%30 Jul 2025
31 Mar 2025$1.3Bup 2.8%30 Apr 2025
31 Dec 2024$1.3Bup 3.8%21 Feb 2025
30 Sep 2024$1.4Bup 2.8%31 Oct 2024
30 Jun 2024$1.3Bup 0.5%31 Jul 2024
31 Mar 2024$1.2Bup 3.1%2 May 2024
31 Dec 2023$1.2Bup 0.5%16 Feb 2024
30 Sep 2023$1.4Bup 3.2%1 Nov 2023
30 Jun 2023$1.3Bup 5.2%3 Aug 2023
31 Mar 2023$1.2Bup 3.7%4 May 2023
31 Dec 2022$1.2Bup 1.1%17 Feb 2023
30 Sep 2022$1.3Bup 4.8%1 Nov 2022
30 Jun 2022$1.2Bup 3.6%2 Aug 2022
31 Mar 2022$1.1Bup 7.2%3 May 2022
31 Dec 2021$1.2Bup 4.9%18 Feb 2022
30 Sep 2021$1.3Bup 15.1%3 Nov 2021
30 Jun 2021$1.2Bup 16.5%4 Aug 2021
31 Mar 2021$1.1Bup 2.5%5 May 2021
31 Dec 2020$1.1Bdown 2.3%19 Feb 2021
30 Sep 2020$1.1Bdown 9.3%4 Nov 2020
30 Jun 2020$1.0Bdown 8.6%29 Jul 2020
31 Mar 2020$1.0Bup 5.2%29 Apr 2020
31 Dec 2019$1.2Bup 7.7%21 Feb 2020
30 Sep 2019$1.2Bup 4.6%31 Oct 2019
30 Jun 2019$1.1Bdown 1.9%31 Jul 2019
31 Mar 2019$992.0Mdown 5.0%1 May 2019
31 Dec 2018$1.1Bdown 4.8%22 Feb 2019
30 Sep 2018$1.2Bdown 1.0%31 Oct 2018
30 Jun 2018$1.1Bup 10.6%1 Aug 2018
31 Mar 2018$1.0Bup 9.9%2 May 2018
31 Dec 2017$1.1B—16 Feb 2018
30 Sep 2017$1.2B—2 Nov 2017
30 Jun 2017$1.0B—2 Aug 2017
31 Mar 2017$950.0M—3 May 2017
30 Sep 2013$1.2Bdown 2.9%7 Nov 2013

Definition

Revenue from this part of the business, as the company names and reports it in its results. Each figure is read from the table or sentence the company printed and kept with its scale and decimals; see data and methodology.

Other operating KPIs of Abbott Laboratories: Diabetes Care revenue · Core Laboratory revenue · Adult Nutritionals revenue · Key Emerging Markets revenue · Pediatric Nutritionals revenue · Cancer Diagnostics revenue · Rapid and Molecular revenue · Electrophysiology revenue · Vascular revenue · Rhythm Management revenue · Rapid Diagnostics revenue · Structural Heart revenue · Heart Failure revenue · Neuromodulation revenue · Point of Care revenue · Molecular revenue · COVID-19 Testing revenue · Medical Devices revenue · Diagnostic Products revenue · Nutritional Products revenue · financial statements

Every KPI and segment of ABT, in the terminal.

Ten years of operating figures, segments, guidance against results, charts and alerts on each new release.